Fundraising FoxQUEoncology Healthier menopause treatments
Atlanta, US · 2 known investors
Find your way into QUEoncology Healthier menopause treatments
Sign up to find every way you can get introduced to QUEoncology Healthier menopause treatments
- Your email: who you already know at QUEoncology Healthier menopause treatments, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the QUEoncology Healthier menopause treatments team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
Investors · 2
Frequently asked questions
- What does QUEoncology Healthier menopause treatments do?
- QUE Oncology develops Q-122, a non-hormonal therapeutic candidate in clinical development for treating vasomotor symptoms in postmenopausal women and cancer patients on hormone therapy. The company was formed as a joint venture between Emory University and University of Queensland's commercialization entity.
- Who are QUEoncology Healthier menopause treatments's investors?
- QUEoncology Healthier menopause treatments's investors include Brandon BioCatalyst, Stoic VC.
- Where is QUEoncology Healthier menopause treatments headquartered?
- QUEoncology Healthier menopause treatments is headquartered in Atlanta, US.